Advisory Services Network’s Inovio Pharmaceuticals INO Stock Holding History

Advisory Services Network’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-33	Closed	-$204	–	2538
2023 Q4	$204	Buy	+33	New	+$163	﹤0.01%	3729
2023 Q2	–	Sell	-117	Closed	-$1.15K	–	2516
2023 Q1	$1.15K	Hold	117	–	–	﹤0.01%	3589
2022 Q4	$2.18K	Buy	+117	New	+$2.65K	﹤0.01%	3411
2021 Q3	–	Sell	-760	Closed	-$85K	–	2315
2021 Q2	$85K	Buy	+760	New	+$73K	﹤0.01%	1705
2021 Q1	–	Sell	-350	Closed	-$37K	–	2129
2020 Q4	$37K	Buy	350 +104	+42%	+$13.8K	﹤0.01%	1834
2020 Q3	$34K	Buy	+246	New	+$51.3K	﹤0.01%	1779
2017 Q4	–	Sell	-18	Closed	-$1K	–	2578
2017 Q3	$1K	Hold	18	–	–	﹤0.01%	2275
2017 Q2	$2K	Hold	18	–	–	﹤0.01%	2106
2017 Q1	$1K	Buy	+18	New	+$1.43K	﹤0.01%	2089
2016 Q3	$2K	Buy	+18	New	+$1.99K	﹤0.01%	1783

Other funds holding INO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Advisory Services Network's INO Position: Q1 2024 in Review

Advisory Services Network sold out of Inovio Pharmaceuticals (INO) in Q1 2024, closing a stake of 33 shares — an estimated $204 sold.

Advisory Services Network first reported a position in INO in Q3 2016 and held it in 10 quarters. The position peaked at $85K in Q2 2021. 89 funds tracked by Wall St. Rank hold INO as of Q1 2024.

Advisory Services Network reported no remaining Inovio Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 33 Inovio Pharmaceuticals shares in Q1 2024, an estimated $204.
Advisory Services Network first reported a position in Inovio Pharmaceuticals in Q3 2016 and held it in 10 quarters.
Advisory Services Network's Inovio Pharmaceuticals position peaked at $85K in Q2 2021.
89 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.